Your partner in Consulting, Advisory & Execution

Learn More

PHARMACEUTICAL WHOLESALE COMPLIANCE & REGULATORY SUPPORT

Keep your pharmaceutical wholesale operation compliant and review-ready

HCPA helps you turn pharmaceutical wholesale requirements into practical systems that protect product integrity and support your day-to-day operations.

Pharmaceutical wholesale compliance extends beyond maintaining your licence. You need to make sure medicines are received, stored, handled, transported and traced correctly, supported by clear procedures, trained staff and reliable records.

In Australia, pharmaceutical wholesalers need to work within the TGA’s Good Wholesaling Practice framework as well as the state or territory requirements that apply to their licence and activities.
HCPA can help you understand what applies, strengthen your systems and make compliance part of the way your wholesale operation works every day.

When urgent pharmaceutical wholesale compliance support may help

Compliance support is not only about maintaining everyday systems. A failed audit, licence issue, cold-chain failure or recall concern may require a more immediate response.

HCPA can help you understand what has been raised, identify what needs immediate attention and build a clear pathway towards remediation.

Speak with an HCPA pharmaceutical compliance consultant

Audit findings

Audits may identify gaps in procedures, training, records, warehouse controls or traceability. The response should address both the finding and the system behind it.

Licence concerns

Regulatory action may affect licence conditions or authorised activities. The response will depend on the jurisdiction, issue and requirements raised by the regulator.

Product integrity issues

Temperature excursions, storage failures or handling issues may affect medicine quality and require affected stock to be identified, contained and assessed.

Recall and traceability issues

Gaps in batch, stock or customer records can make recalls harder to manage and may require immediate action to restore reliable product traceability.

Key pharmaceutical wholesale compliance requirements

Your compliance systems need to protect medicine quality and maintain traceability from the moment stock arrives through to storage, transport and supply. The TGA’s Australian Code of Good Wholesaling Practice provides the key framework for these controls.

The requirements that matter most will depend on your products and operations, but key areas include:

Quality systems and procedures

Documented procedures should cover how medicines are received, stored, handled and supplied, supported by clear staff responsibilities, training and reliable records.

Regular review also helps ensure procedures continue to reflect how the wholesale operation works in practice.

Cold-chain and temperature control

Medicines must be stored under the conditions required for the individual product, whether that involves ambient, refrigerated or frozen storage.

For cold-chain medicines, 2°C to 8°C is a common temperature range, although the conditions specified for the individual medicine always take precedence. Temperature-sensitive storage needs appropriate monitoring, with required records retained for at least one year. View the TGA’s cold-chain and storage requirements

You also need a clear process for managing temperature excursions, assessing affected stock and recording the outcome.

Product and batch traceability

Records should show what products entered the business, what stock is currently held and where it has been supplied.

Reliable traceability allows affected batches and customers to be identified quickly when a recall, market action or other product issue occurs.

Facilities, equipment, utilities and manufacturing processes need appropriate qualification or validation to demonstrate that they perform as intended and continue to remain under control.

Product quality and records

Wholesalers do not manufacture the finished medicines they distribute, but they still need to protect product quality while those medicines are in their control.

Records should support product quality and receiving processes and, depending on the supplier arrangements, may include Certificates of Analysis or Certificates of Release.

Recall procedures

Recall procedures should allow affected stock, batches and customers to be identified quickly, with clear processes for quarantine, returns and other required market actions.

Wholesalers need to know what affected stock remains on hand, where supplied products have gone and what action needs to be taken.

Security and stock controls

Security and stock controls should reflect the medicines handled and their level of risk. Additional requirements can apply to Schedule 8 controlled drugs and other products with high illicit value. View the TGA’s security requirements.

Personnel need appropriate training and clear responsibilities, with effective controls over the receipt, handling, storage and movement of materials and products throughout manufacturing.

HCPA can help bring these requirements together into practical systems that are easier to manage as part of your day-to-day wholesale operation.

Pharmaceutical wholesale monitoring and review readiness

Good compliance is easier to maintain when your systems are reviewed regularly, rather than only when an inspection or issue arises.

The Good Wholesaling Practice Code calls for regular, risk-based audits across areas such as quality systems, staff training, traceability, temperature records, storage controls, recalls and record keeping.

Regular reviews should consider areas such as:

  • quality procedures and records

  • staff training and responsibilities

  • temperature and cold-chain controls

  • stock and batch traceability

  • security and warehouse controls

  • recall and market-action procedures

  • changes to products or suppliers

  • outstanding corrective actions

Regular reviews can help identify outdated procedures, control gaps and changes in how the operation works before they develop into larger compliance issues.

HCPA can help review your systems, identify gaps and strengthen your pharmaceutical wholesale compliance before issues arise.

Speak with an HCPA pharmaceutical compliance consultant

What to do after a pharmaceutical wholesale compliance finding

The right response will depend on the finding, regulator and timeframe involved, but four priorities can help bring structure to the process.

Step 1

Understand the finding

Identify what has been raised, which requirements or licence conditions are involved and when any response or corrective action is due.

Step 2

Control immediate risks

If product quality, storage or traceability may be affected, identify what stock or activities need to be contained while the issue is investigated.

Step 3

Investigate the cause

Review procedures, records, training and operating practices to understand why the problem occurred rather than treating the finding in isolation.

Step 4

Evidence the correction

Document what changed, who was responsible, when actions were completed and what evidence demonstrates that the corrective action is working.

Why choose HCPA for pharmaceutical wholesale compliance?

Compliance works best when it supports the way your business actually operates.

HCPA brings your quality systems, warehouse controls, staff procedures and regulatory requirements together so compliance works as part of the day-to-day operation.

Where a compliance issue has already arisen, HCPA can also help investigate the underlying cause, develop corrective actions and strengthen the systems behind the finding.

0

businesses supported

0+

consultants

$0B

client revenue generated

Our broader compliance experience includes quality-system development, root-cause analysis, audit support and resolving compliance gaps. For pharmaceutical wholesalers, we apply that experience across quality systems, warehouse controls, traceability, recalls and corrective action.

Frequently asked questions about pharmaceutical wholesale compliance

In Australia, businesses referring to Good Distribution Practice or GDP should generally look to the Good Wholesaling Practice requirements that apply to their wholesale activities.

The Code covers areas including premises, storage, personnel, stock handling, transport, complaints and recalls, documentation, cold-chain medicines and security.

Businesses searching for “Good Distribution Practice” or GDP should therefore make sure their systems are aligned with the Australian Good Wholesaling Practice requirements that apply to their activities.

These controls should work as one connected system.

Cold-chain medicines need to remain within their required temperature conditions, supported by monitoring, alarms, maintenance and excursion procedures. Product records should allow batches to be followed from receipt through to supply, while recall procedures should allow affected stock and customers to be identified and acted on quickly.

HCPA can help review how these processes work together within your operation.

You should maintain accurate records of products received and supplied, with information that can be accessed quickly when required.

For market actions, the TGA expects wholesalers and distributors to be able to trace batches through their stock-control system and identify customers, contact details, the batches supplied and when they were supplied.

For cold-chain medicines, the Good Wholesaling Practice Code states that maximum and minimum temperatures should be recorded at least once every 24 hours and retained for at least one year.

The calibration and function of temperature-monitoring equipment, alarms and associated equipment should also be checked annually.

If storage conditions deviate from the conditions recommended by the sponsor, the suitability of the affected medicine needs to be resolved and the outcome recorded.

Your quality system should have a defined temperature-excursion process so staff know what to quarantine, who to contact and what evidence needs to be retained.

The wholesaler needs to be able to respond effectively when a sponsor initiates a recall or other market action.

This includes tracing affected batches, identifying customers supplied, quarantining relevant stock, handling returns and maintaining the necessary records.

The Good Wholesaling Practice Code calls for regular audits, with the frequency determined by risk.

Security risk-management plans should be reviewed at least annually, and security audits should occur no less frequently than once every 12 months.

It can. The TGA’s definition of a wholesaler includes third-party logistics and distribution providers that store or supply relevant scheduled medicines by wholesale.

The regulatory responsibilities of the parties should therefore be understood clearly when pharmaceutical warehousing or distribution is outsourced.

Start by identifying exactly what has been raised, which requirements are affected and whether immediate action is needed to protect medicines or restrict affected activities.

Then review the relevant evidence, determine the underlying cause and develop corrective actions that address both the finding and the system behind it.

HCPA can help assess the findings, identify the root cause and build a practical remediation plan.

A corrective and preventive action plan should identify the finding, immediate containment, root cause, corrective action, preventive action, responsibilities, timeframe and evidence of implementation.

It should also explain how the improvement will be monitored so the same problem is less likely to recur.

A traceability gap can make it difficult to identify affected stock and customers quickly during a recall or market action.

The issue should be investigated to identify where the records or stock-control process failed and what changes are needed to restore reliable batch traceability.

HCPA can help identify the breakdown and strengthen the records and processes behind it.

Yes. HCPA can review corrective actions, supporting evidence and operational systems to help determine whether the identified gaps have been properly addressed.

The goal is to demonstrate that the improvement is working in practice, not simply that documents have been updated.

Once the finding has been addressed, the focus should return to ongoing compliance and making sure the corrective action remains effective.

Regular audits, training, procedure reviews, traceability checks and warehouse controls can help keep the improvements in place.

Related pharmaceutical wholesale resources

Starting your manufacturing business

Ready to start your pharmaceutical wholesale business?

HCPA can help confirm your licensing pathway, prepare premises and storage requirements, establish quality systems and documentation, and get your operation approval-ready.

Get started

Growing your manufacturing business

Ready to grow your pharmaceutical manufacturing business?

Identify suitable clients, strengthen your market proposition and pursue partnerships and supply contracts that fit your manufacturing capabilities and support sustainable growth.

Start Growing
A smiling woman in a white blazer shakes hands with another person in a business setting.
Smiling man with glasses wearing a plaid shirt against a peach-colored background.

Contact Us

Let's discuss how we can help you achieve your business goals

Call us at (03) 9084 7427

Or Fill The Form Below

HCPA AU - Quote Form

We’re Super Responsive.